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TUMOR-LIKE MULTIPLE SCLEROSIS
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SUMMARY – Multiple sclerosis is a chronic demyelinating disease of the central nervous sy-
stem. Tumor-like manifestation of multiple sclerosis is one of the rare clinical variants and it is 
frequently misdiagnosed. This is a report on a 45-year-old man who presented with right-sided 
hemiparesis. Initial computed tomography and magnetic resonance imaging studies of the brain 
revealed a large hyperintense signal lesion in the left hemisphere surrounding the cerebral edema. 
Low grade glioma was among the likely differential diagnoses. The patient underwent surgery. Brain 
biopsy showed demyelination. Lumbar puncture was performed and cerebrospinal fluid was positive 
for intrathecal synthesis of immunoglobulins. Other findings were compatible with the unusual 
form of multiple sclerosis. This case report illustrates a demyelinating process mimicking tumor 
lesions of the brain and it is of high importance to consider the diagnosis of multiple sclerosis on 
differential diagnosis of a tumor-like lesion of the central nervous system. 
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Introduction
Multiple sclerosis is a chronic demyelinating dis-
ease of the central nervous system. Usually, multiple 
sclerosis is a disease of young adults, with a higher 
predominance in women compared to men and the 
disease onset typically between the ages of 20 and 40 
years1. Multiple sclerosis is diagnosed on the basis of 
clinical and/or radiographic evidence of disease dis-
semination in time and space2,3. On magnetic reso-
nance imaging (MRI), multiple sclerosis plaques are 
usually found, small and irregular, with well-defined 
margins4. Edema and mass effect are uncommon 
features of multiple sclerosis plaques. A solitary de-
myelinating lesion greater than 2 cm is defined as a 
tumefactive demyelinating lesion5. Tumor-like mani-
festation of multiple sclerosis is one of the rare clini-
cal variants and the presence of tumefactive lesions on 
MRI can cause diagnostic difficulties because several 
neoplastic and infective diseases of the brain may have 
similar imaging characteristics6-9.
Case Report
This is a report on a 45-year-old male patient who 
presented with a 10-day history of right-sided extrem-
ity weakness. His medical history included attacks of 
dizziness in his twenties. A month before admission 
to our Department, he had weakness of the right leg, 
which was connected with low back pain. 
Physical examination confirmed right-sided mild 
hemiparesis, increased deep tendon reflexes on the 
right limbs and positive Babinski sign.
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Computed tomography (CT) scan of his brain 
showed a large solitary left frontoparietal hypodense 
white matter lesion. MRI scan showed a large left 
frontoparietal mass surrounding the edema (Fig. 1). 
Low grade glioma was among the likely differential 
diagnoses.
We consulted a neurosurgeon and the patient un-
derwent surgery for resection of the lesion.
Postoperative pathology indicated an extensive in-
flammatory cell reaction, the presence of CD-68 posi-
tive macrophages and astrocytic proliferation through 
the white matter areas, with uninvolved grey matter, 
also with the absence of myelin (Fig. 2). 
Lumbar puncture was performed and cerebrospi-
nal fluid was positive for intrathecal synthesis of im-
munoglobulins. Other findings were compatible with 
an unusual form of multiple sclerosis10. Follow up 
MRI of the brain showed several new demyelinating 
lesions in white matter (Fig. 3).
The patient’s condition improved upon intravenous 
infusion of steroids (1 g for 5 days)11. Two months 
later, he had a right focal tonic-clonic seizure with 
secondary generalization. Carbamazepine in a dose of 
400 mg per day was administered to prevent seizure 
recurrence. On follow up visit, the patient was seizure 
free for 3 months. 
Discussion
Most of the knowledge about tumefactive form 
of multiple sclerosis is derived from case reports and 
series of case reports12-14.  In 2008, Lucchineti et al. 
Fig. 1. MRI of the brain showing a large left frontopari-
etal mass surrounding edema.
Fig. 2. Lymphocytic perivascular infiltrate with the sur-
rounding lipid laden macrophages and reactive astrocytes 
is typical in demyelinating lesions. (hemalaun & eosin, 
X400)
Fig. 3. Follow up MRI of the brain.
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published the results of a study including a cohort of 
168 biopsy proven tumefactive multiple sclerosis cas-
es. The most common presenting symptoms were mo-
tor, cognitive, cerebellar and brainstem dysfunction. 
Atypical symptoms were headache, seizures, aphasia, 
agnosia, and cortical sensory loss. During the follow 
up of less than 5 years, two-thirds of these patients 
developed relapsing-remitting multiple sclerosis and 
only one-third of patients had the monophasic form of 
disease, which differed from the previously published 
reports12,13.
Our case report illustrates the demyelinating pro-
cess mimicking tumor lesions of the brain, which led 
to surgical procedure. MRI of the brain was highly 
suspect of low grade glioma. Some recent studies of 
MRI features suggest differences that can be help-
ful in distinguishing the tumefactive demyelination 
lesions from neoplasms14,15. The majority of patients 
with the complete ring enhancement pattern on brain 
MRI have tumefactive multiple sclerosis16. It is very 
important to perform MRI spectroscopy because el-
evation of the glutamate/glutamine peaks is not seen 
in neoplastic diseases of the brain17. For clinician, it is 
important to consider multiple sclerosis on differential 
diagnosis of a tumor-like lesion of the central nervous 
system to avoid invasive diagnostic procedures and 
aggressive treatment.
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Sažetak
TUMEFAKTIVNI OBLIK MULTIPLE SKLEROZE
Vanja Bašić Kes, Marijan Cesarik, Lejla Ćorić, Iris Zavoreo, Krešimir Rotim, Vili Beroš, 
Leo Pažanin, Sara Drnasin i Vida Demarin
 
Multipla skleroza je kronična demijelinizacijska bolest središnjega živčanog sustava. Pojava tumefaktivnog oblika mul-
tiple skleroze je jedna od rijetkih kliničkih varijanta i često je pogrešno dijagnosticirana. Ovo je prikaz slučaja 45-godišnjeg 
muškarca s desnostranom hemiparezom. Početna kompjutorizirana tomografija i magnetska rezonanca mozga prikazale su 
veliku hiperintenzivnu leziju lijeve hemisfere mozga okruženu cerebralnim edemom. Diferencijalno dijagnostički nalaz je 
upućivao na nisko diferencirani glioblastom mozga. Bolesnik je podvrgnut kirurškom zahvatu. Biospija mozga potvrdila 
je demijelinizaciju. Učinjena je lumbalna punkcija i nalaz likvora ukazao je na intratekalnu sintezu imunoglobulina. Drugi 
su nalazi dijagnostičke obrade bili u skladu s rijetkim oblikom multiple skleroze. Ovaj prikaz slučaja ilustrira demijelini-
zacijski proces koji se prikazao kao tumoska lezija mozga i od iznimne je važnosti razmotriti dijagnozu multiple skleroze 
kao diferencijanu dijagnozu tumefaktivne lezije središnjega živčanog sustava.
Ključne riječi: Tumefaktivna lezija; Multipla skleroza
